Welcome to the Crinetics Pharmaceuticals Corporate Update Conference Call. [Operator Instructions] I will now turn the call over to Gayathri Diwakar, Head of Investor Relations. Please go ahead. Thank ...

Nonclassical congenital adrenal hyperplasia (NCAH) can lead to the production of excess male hormones. It is usually a mild condition and often doesn’t need to be treated if there are no symptoms.

The study will be conducted in three phases. Part A is a Phase 2, open-label, semi-sequential dose-ranging portion of the ...

The diagnosis of polycystic ovary syndrome, a common hyperandrogenic disorder, requires the exclusion of several diseases that might show similar symptoms at presentation, for example nonclassical ...

A high proportion of cases of congenital adrenal hyperplasia (CAH) are attributable to deficiency of 21-hydroxylase, which results in presentation of ambiguous genitalia at birth in girls but with no ...

SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at 8:30 ...

Northwestern University researchers have developed the first device that can continuously track a fetus's vital signs while ...

The following slide deck was published by Crinetics Pharmaceuticals, Inc. in conjunction with this event.

Polycystic ovary syndrome (PCOS) is often seen as the default explanation for irregular periods, stubborn acne, or unexplained weight changes. Countless women leave their doctor’s office convinced ...

Professor of Microbiology and Clinical Microbiology at Alma Mater Studiorum, University of Bologna (Italy) Laboratory of Virology of the Operative Unit of Microbiology at St. Orsola Hospital This ...